Determination of IDH1 Mutational Burden and Clearance Via Next-Generation Sequencing in Patients with IDH1 Mutation-Positive Hematologic Malignancies Receiving AG-120, a First-in-Class Inhibitor of Mutant IDH1
Year: 2016
Type: article
Source: Blood
Authors: Courtney D DiNardo, Stéphane de Botton, Eytan M Stein, Gail J. Roboz, Ronan T Swords, Daniel A Pollyea, Amir T. Fathi, Robert Collins, Jessica K Altman, Ian W. Flinn, Gabriel N Mannis, Alice S. Mims, James M. Foran, Arnaud Pigneux, Gabrielle T Prince, Geoffrey L Uy, Martin S. Tallman, Hagop M. Kantarjian, Hua Liu, Eyal C Attar, Jennifer Sacolick, Katharine Yen, Jonathan B Hurov, Sung Choe, Bin Wu, Richard M. Stone
Institutions: The University of Texas MD Anderson Cancer Center, Institut Gustave Roussy, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, University of Miami, Sylvester Comprehensive Cancer Center, University of Colorado Cancer Center, Massachusetts General Hospital, The University of Texas Southwestern Medical Center, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Sarah Cannon, University of California, San Francisco, The Ohio State University, Mayo Clinic in Florida, Centre Hospitalier Universitaire de Bordeaux, Hôpital Cardiologique du Haut-Lévêque, Johns Hopkins Hospital, Washington University in St. Louis, Agios Pharmaceuticals (United States), Dana-Farber Cancer Institute
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2586529912